This compound is a brominated pteridine derivative commonly used as an intermediate in the synthesis of pharmaceuticals. It features a pteridine ring system with amine and bromomethyl substituents, typically supplied in a hydrobromide salt form.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Telmisartan methyl ester
pharmaceutical intermediate
(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
pharmaceutical intermediate
(1S,5R)-1-(3-fluorophenyl)-3-oxabicyclo(3.1.0)hexan-2-one
pharmaceutical intermediate
Desethyleneciprofloxacin monohydrochloride
pharmaceutical intermediate
2,4-Diamino-6-(hydroxymethyl)pteridine hydrochloride
pharmaceutical intermediate
6-(Chloromethyl)pteridine-2,4-diamine monohydrochloride
pharmaceutical intermediate
6-(bromomethyl)pteridine-2,4-diamine;hydrobromide
KMQIBGKVZDBGAH-UHFFFAOYSA-N
C1=C(N=C2C(=NC(=NC2=N1)N)N)CBr.Br
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.